Regulation of interferon-t (IFNt) production, a conceptus secretory protein implicated in the process of maternal recognition of pregnancy, has not been fully elucidated. Among more than 10 ovine IFNt (oIFNt) gene sequences characterized, approximately 75% of oIFNt transcripts expressed in utero is derived from oIFNt-o10 gene and amounts of transcripts from other oIFNt genes such as oIFNt-o8 or oIFNt-o2 are minimal. It was hypothesized that the variation in expression levels exhibited by oIFNt-o10 and oIFNt-o8/-o2 genes was due to differences in the proximal promoter regions of these oIFNt genes. To test this hypothesis, transient transfection experiments with human choriocarcinoma JEG3 cells were executed with deleted and/or mutated 5 0 -upstream regions of these oIFNt genes attached to the chloramphenicol acetyltransferase (CAT) reporter gene. Because only the Ets-2 binding site located in the oIFNt-o10 gene appeared to differentiate the expression levels of these constructs, the 6 base pair (bp) Ets-2 sequence from the oIFNt-o10 gene inserted into the oIFNt-o8/-o2 gene-reporter construct was examined. The insertion of this Ets-2 binding site into the oIFNt-o8/o2-reporter construct failed to increase the degree of transactivation. Rather than this 6 bp sequence, a 22 bp sequence of the proximal promoter region, including the Ets-2 binding site, of the oIFNt-o10 gene was required for oIFNt-o8/-o2-reporter transactivation. By electrophoretic mobility shift assay (EMSA), nuclear protein(s) bound to this 22 bp from the oIFNt-o10 and oIFNt-o8/o2 genes differed. These results suggest that the short promoter region including the Ets-2 binding site, not the Ets-2 binding region itself, may determine different levels of oIFNt gene expressions seen in utero. Mol. Reprod. Dev. 72: 7-15, 2005. ß 2005 Wiley-Liss, Inc.
INTRODUCTION
Interferon-t (IFNt), produced by peri-implantation blastocysts, is a major protein implicated in the process of maternal recognition of pregnancy in ruminant ungulates (Godkin et al., 1982; Imakawa et al., 1987; Roberts et al., 1992) . IFNt acts on the uterine epithelium and attenuates secretion of a luteolysin, prostaglandin F2a (PGF2a), resulting in the maintenance of corpus luteum (CL) function . Based on cDNA and amino acid sequences, this protein is classified into type I IFNs (Imakawa et al., 1987 Roberts et al., 1992) . In addition to structural similarities, IFNt polypeptides exhibit antiviral, antiproliferative, and immunomodulately activities like other IFNs (Pontzer et al., 1988 (Pontzer et al., , 1991 Roberts et al., 1989) . The expression of IFNt is quite different from that of other type I IFNs such as IFNa and IFNb that are induced by viruses or double stranded RNA and maintained for only a few hours (Pestka, 1983; Farin et al., 1991) . IFNt exhibits temporal and spatial expression since its production is restricted to trophoblast cells during peri-implantation periods (Hansen et al., 1988; Farin et al., 1989; Guillomot et al., 1990; Demmers et al., 2001) . In fact, ovine IFNt (oIFNt) production begins on day 8 of pregnancy (day 0 ¼ first day of estrus). Its production increases as the conceptus elongates and reaches the highest production (up to 100 mg/conceptus/ 24 hr) on day 16, just before the attachment of the conceptus to the uterine epithelium (Godkin et al., 1982; Ashworth and Bazer, 1989; Imakawa et al., 1995) . By day 22, when the placenta formation is initiated, oIFNt is no longer detected (Godkin et al., 1982) .
So far more than 10 IFNt genes or cDNAs have been isolated and characterized for the ovine and bovine species, which exhibit a high degree of similarity within and among ruminants Nephew et al., 1993; Ryan and Womack, 1993; Imakawa et al., 1994; Ealy et al., 1998; Alexenko et al., 2000; Ealy et al., 2001) . The majority of oIFNt expressed in utero is derived from one gene, oIFNt-o10, whose transcripts constitute more than 75% of oIFNt mRNAs (Nephew et al., 1993) . By transient transfection of reporter constructs with deleted or mutated 5 0 -upstream regions of the oIFNt-o10 gene in human choriocarcinoma JEG3 cells, the AP-1 binding site in the distal enhancer region was shown to be effective in oIFNt-reporter transactivation (Yamaguchi et al., 1999 (Yamaguchi et al., , 2000 . At the proximal promoter region, there exists another transactivation domain to which the transcription factor Ets-2 binds (Ezashi et al., 1998; Yamaguchi et al., 1999) . Ezashi et al. (2001) have found that the action of Ets-2 on bovine IFNt (bIFNt) is inhibited while Oct-4 binds to Ets-2 protein. Once Oct-4 expression subsides, Ets-2 becomes effective in the activation of bIFNt gene transcription. Recently, a transcription co-activator, cAMP-response element binding protein-binding protein (CBP), was shown to activate oIFNt-o10 gene transcription (Xu et al., 2003) . Both AP-1 and Ets-2 binding domains are located on the CBP polypeptide sequences, to which these transcription factors bound, possibly resulting in further activation of oIFNt-o10 gene transcription.
In contrast to oIFNt-o10, other oIFNt genes like oIFNt-o8 and -o2, whose coding regions are >95% identical to that of oIFNt-o10, are expressed at very low levels in vivo (Nephew et al., 1993) . The homologies of their 5 0 -upstream regions (between À654 and À1 base pair, bp) are approximately 90%. The remaining 10% sequences and/or specific nucleotides may be responsible for the different degrees of expression observed for oIFNt-o10 and oIFNt-o8 or -o2. However, molecular mechanisms of these oIFNt genes whose expressions are limited have not been characterized.
To understand the molecular mechanisms responsible for different degrees of oIFNt gene transcriptions, three oIFNt genes, oIFNt-o10, -o8, and -o2, were examined using transient transfection analyses and electrophoretic mobility shift assays (EMSA).
MATERIALS AND METHODS
Plasmid Constructions The upstream regions of oIFNt-o10, -o8, and -o2 (Nephew et al., 1993 ; GenBank accession numbers M88773, M88772, and M88770, respectively) between À654 and þ51 bp were amplified through polymerase chain reaction (PCR) with specific primers (Yamaguchi et al., 1999) . Each of these products was inserted into the PstI site of chloramphenicol acetyltransferase (CAT) basic vector (Promega, Madison, WI) . For the preparation of chimeric enhancer (E)/promoter (P) sequences, the upstream regions from À654 to À452 bp of oIFNt-o8 and -o2 genes were replaced with the same region of oIFNt-o10, termed o10E þ o8P and o10E þ o2P, respectively. The regions from À452 to þ51 bp of oIFNt-o8 and -o2 were replaced with the same region of oIFNt-o10, termed o8E þ o10P and o2E þ o10P, respectively. AP-1 binding site, TGTGTCA, located at À594 to À588 bp of the oIFNt-o10 gene's upstream region was point mutated to TGTGCAA by inverse PCR procedure using the primers consisting of desired nucleotide changes (Yamaguchi et al., 1999) . Using the same method, Ets-2 binding site located at À77 to À72 bp of oIFNt-o10 gene's upstream region was also mutated as CAGGAA to CATTAA. Ets-2 binding site of oIFNt-o10 (CAGGAA) and the sequence found at the equivalent region of oIFNt-o8 (ATGAAA) were interchanged, resulting in oIFNt-o10 with ATGAAA (o10-M6) and oIFNt-o8 with CAGGAA (o8-M6) constructs, respectively. The 23 bp of oIFNt-o8 (GAAAACGCAAATGAAAGTGAGAG) was replaced with the 22 bp sequences of oIFNt-o10 (GAAAACAAACAGGAAGTGAGGG; Ets-2 binding site is underlined), resulting in the construct oIFNt-o8-M22 (o8-M22). Expression vectors of murine c-Jun and c-Fos were driven by Rous Sarcoma Virus (RSV) E/P of pRVSV vector (Miyazawa et al., 1993) . The Ets-2 expression vector was a pSG5-based construct and driven by the SV40 P/E (Wakiya et al., 1996) .
Cell Culture and Transient Transfection
Human choriocarcinoma JEG3 cells (HTB36, American type culture collection) were cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich, St. Lois, MO) supplemented with 10% (v/v) fetal bovine serum (FBS; Sigma-Aldrich), 40 U/ml penicillin, and 40 mg/ml streptomysin under 5% CO 2 at 378C. One day before transient transfection was performed, JEG3 cells were re-plated onto 6-well plastic culture plates and at 50%-60% confluency, they were transiently transfected with reporter constructs using TransFast (cationic lipid; Promega) according to the manufacturer's protocol (Yamaguchi et al., 1999) . In each well of 6-well plates, 3 mg of oIFNt-CAT reporter plasmids, 0.2 mg of b-gal plasmids, and 9 mg of TransFast mixed in 1 ml DMEM was overlaid on the cells. After 1 hr incubation at 378C, 3 ml of DMEM was added to each well and transfected cells were cultured for 48 hr. The effects of nuclear factors on oIFNt gene-reporter transactivation were determined by co-transfection analyses. One micrograms of expression vectors or pRVSV empty vector was cotransfected along with 3 mg of oIFNt-CAT plasmids.
Chloramphenicol Acetyltransferase (CAT) Assay CAT activity was measured using CAT ELISA kit (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's protocol. After 48 hr incubation, JEG3 cells were washed with phosphate-buffered saline (PBS) and lysed by the addition of 600 ml Lysis buffer (Promega), and cell debris was then removed by centrifugation. Extracts (200 ml) were added to each well of anti-CAT-coated microtiter plate, which was then incubated at 378C for 1 hr. The well was washed with the washing buffer (10 mM sodium phosphate, 150 mM sodium chloride, and 0.1% Tween 20). To each well, 400 ng of anti-CAT-Digoxigenin were added and the plate was incubated at 378C for 1 hr. After the washing step, 150 mU of anti-digoxigenin-peroxidase was added to each well and incubation continued at 378C for 1 hr. The wells were washed again, 200 ml of peroxidase substrate was added and incubated at room temperature (22-258C) for 30 min. CAT activities were measured by determining the absorbance of each sample at 405 nm. b-gal activities of each sample were also determined by using b-gal ELISA kit (Roche Diagnostics). CAT activity resulting from various oIFNt-reporter constructs was normalized through the determination of transcriptional efficiency with b-gal activity. In the figures, CAT activities were expressed as fold activation relative to an appropriate control within the experiment.
Preparation of Nuclear Extracts and EMSA Nuclear proteins were extracted from JEG3 cells following the protocol described by Angel et al. (1987) . Cells were grown to 70%-80% confluency, then washed with PBS and lifted off the plate. The remaining procedures were described by Matsuda et al. (2004) .
Bindings of nuclear proteins extracted from JEG3 cells to the 5 0 -upstream region of oIFNt-o10 or -o8 were examined by EMSA. The three oligonucleotide probes examined were the 22 bp of oIFNt-o10 gene's upstream region including Ets-2 binding site, 23 bp of oIFNt-o8 (equivalent to the 22 bp of oIFNt-o10), and 23 bp of oIFNt-o8 sequences, to which Ets-2 binding site from the oIFNt-o10 gene was inserted (o8-M6 probe, 5 0 -GAAAACGCAACAGGAAGT-GAGAG-3 0 ; inserted sequence is underlined). These probes were end-labeled with [g-32 P] ATP (6,000 Ci/mmol, NEN, Boston, MA) and T4 polynucleotide kinase (Takara, Shiga, Japan). Endlabeled oligonucleotide probes were cleaned by ethanol precipitation, and annealed with non-labeled antisense oligonucleotides by placing them into a 958C water bath and slowly cooling to room temperature. The sequences of consensus Ets-2 and Sp-1 oligonucleotides were 5 0 -CTAGGACCAGGAAGTGGGAGT-3 0 and 5 0 -ATTCGA-TCGGGGCGGGGCGAGC-3 0 , respectively (binding site of each is underlined), and competitors of oIFNt-o10, oIFNt-o8, Ets-2 consensus, and Sp-1 consensus were constructed by annealing non-labeled sense and antisense oligonucleotides. JEG3 nuclear proteins (10 mg) were incubated on ice for 15 min in the binding buffer (7 mM HEPES (pH 7.9), 0.5 mM MgCl 2 , 35 mM KCl, 7% (v/v) glycerol, 70 nM EDTA, 0.3 mM DTT, 100 mg/ml poly(dI-dC), and 50 mg/ml BSA) with or without a 100-fold molar excess of unlabeled competitor. End-labeled probe (2-3 ng/probe, 3,000 cpm) was added and incubated at room temperature for 15 min. Reaction mixtures were loaded onto a 5% polyacrylamide gel and upon the completion of electrophoresis, the gel was dried and autoradiographed.
Statistical Analysis
The results of CAT assays were expressed as means AE SEM. Differences in fold activation were examined by one-way ANOVA followed by Tukey's multiple comparison tests.
RESULTS

Contribution of Proximal and Distal 5
0 -Upstream Regions on oIFNt Gene Transcription Reporter plasmids constructed with the wild-type 5 0 -upstream sequences of oIFNt-o10, -o8 or -o2 genes were examined for the degrees of transactivation using a transient transfection method (Fig. 1) . Similarly to its expression in vivo, the reporter plasmid with the upstream region of the oIFNt-o10 gene exhibited high CAT activity whereas the one with oIFNt-o8 or -o2 gene had very low activity, less than 20% of that expressed by Wild type and chimeric enhancer/promoter analyses of the 5 0 -upstream regions of oIFNt-o10 and oIFNt-o8 or -o2 reporter plasmid transfected into JEG3 cells. Distal and proximal upstream regions between À452 and þ51 bp of oIFNt-o10, -o8, and -o2 were interchanged at the Hind III restriction site (o10E þ o8P, o10E þ o2P, o8E þ o10P, o2E þ o10P) and transcriptional activities were compared to those of wild-type oIFNt-o10, -o8, and -o2. Results are expressed as relative CAT activity to that of the oIFNt-o10-reporter plasmid and values represent means AE SEM. Results with different letters differ at P < 0.01 (n ¼ 4 each).
oIFNt-o10. To determine the upstream region critical for high or low levels of oIFNt gene transcriptions, distal and proximal regions of oIFNt-o10, -o8 or -o2 were fused at the Hind III restriction site (À452 bp) and the importance of distal (E) and proximal (P) regions was evaluated (Fig. 1) . Proximal region of oIFNt-o8 or -o2 fused to the distal region of oIFNt-o10 (o10E þ o8P and o10E þ o2P, respectively) exhibited the same level of transactivation as that of the wild-type oIFNt-o8-reporter plasmid. However, the proximal region of oIFNt-o10 fused to the distal region of oIFNt-o8 or -o2 (o8E þ o10P or o2E þ o10P) exhibited a high degree of transactivation similar to that of the wildtype oIFNt-o10.
Examination of Distal AP-1 and Proximal Ets-2
Binding Sites on oIFNt Gene Transcription Because AP-1 and Ets-2 binding sequences are located in the oIFNt-o10's distal enhancer and proximal promoter regions, respectively, the effects of these sites on the transactivation of oIFNt-reporter constructs were examined through point mutations to these binding sites (Fig. 2) . Two-base mutation to the AP-1 binding site resulted in the reduction of CAT activity, approximately 50% of that of the wild-type oIFNt-o10. Two-base mutation to the Ets-2 binding site also reduced the activity of oIFNt-o10 to less than 40%. When both AP-1 and Ets-2 binding sites were point mutated, its CAT activity became approximately 25% of that of the wildtype oIFNt-o10. In addition, co-transfection with AP-1 or Ets-2 expression plasmid failed to activate mutated constructs (Fig. 3A,B) . These experiments show that it is a lack of binding of these factors to the mutated templates rather than the lack of these factors themselves.
Examination of Proximal Ets-2 Binding Site
on oIFNt Gene Transcription The importance of the Ets-2 binding site of the oIFNto10 promoter region was further examined by exchanging the Ets-2 binding site of oIFNt-o10 (CAGGAA) with the sequences of oIFNt-o8 (ATGAAA) located at the same region (Fig. 4A ). Ets-2 site was originally described as a 10 bp sequence (Wasylyk et al., 1993) . The 6 bp change made in this study was due to the fact that several nucleotides at both side of the 6 bp sequence were the same between oIFNt-o10 and -o8 genes. When the 6 base sequence from oIFNt-o8 was inserted into the equivalent site of oIFNt-o10 (o10-M6), the CAT activity was reduced to 5% of the wild-type oIFNt-o10 (Fig. 4B) . The insertion of Ets-2 binding sequence to the equivalent region of the oIFNt-o8-reporter construct (o8-M6), however, did not increase the degree of transactivation, which was at the same level as the wild-type oIFNt-o8 and less than that of oIFNt-o10 (Fig. 4B) .
Examination of a Short Promoter
Region of the oIFNs Genes The 22 bp sequence including the Ets-2 binding site of oIFNt-o10 (GAAAAC-AAACAGGAAGTGAGGG, Ets-2 binding site underlined) was inserted into the equivalent site of oIFNt-o8's proximal promoter region (o8-M22; Fig. 5A ). Its degree of transactivation was then compared with that of the wild-type oIFNt-o10, wild-type oIFNt-o8, and o8-M6 constructs. Differing from o8-M6, which had a low degree of transactivation similar to the wild-type oIFNt-o8, o8-M22 construct had strong transactivation similar to that of the wild-type oIFNt-o10 (Fig. 5B ).
Examination of a Nuclear Protein Binding to
the Short Promoter Region of oIFNs Gene The bindings of JEG3 nuclear protein to 22/23 bp of oIFNt-o10/o8 promoter regions were examined by EMSA (Fig. 6) . Protein bindings to oIFNt-o10 and -o8 probes appeared specific since they disappeared when nonlabeled respective probes, competitors, were added whereas an unrelated competitor, Sp-1, did not inhibit the binding (Fig. 6) . A second band appeared below the Ets-2 binding disappeared with the use of unrelated Sp-1 competitor, but the further characterization of this protein was not made. Bands detected with oIFNt-o10 and -o8 probes exhibited different sizes. The protein that bound to oIFNt-o10 probe appeared Ets-2 since the band disappeared by the use of Ets-2 consensus sequence, which had been shown previously in the laboratory (Yamaguchi et al., 2000) . However, a protein bound to oIFNt-o8 probe, larger than the one with oIFNt-o10, may not be Ets-2 as it was not competed off with the Ets-2 consensus competitor (Fig. 6) .
Because the o8-M6 construct did not exhibit a high degree of transactivation (Fig. 4) , protein binding to this probe was also examined. The 23 bp of o8-M6 probe showed specific binding, the same pattern as oIFNt-o10 probe, though the binding appeared a little weaker than that of the oIFNt-o10 probe (Fig. 7) . This result indicated that Ets-2 protein could bind to the o8-M6 region, oIFNt-o8 with the Ets-2 sequence. DISCUSSION This is the first report that investigates the molecular basis for differential transcription of oIFNt genes in the ovine uterus. The results demonstrated that high and low expression levels from oIFNt-o10 and oIFNt-o8/ o2 genes, respectively, are probably due to a short, contiguous region of the promoter that is unique to the oIFNt-o10 gene. Because a ruminant trophoblast cell line proper for IFNt analyses has not been established, human choriocarcinoma JEG3 or JAR cells have been . Transcriptional activities of oIFNt-o10 or -o8 after the 6 bp replacement at Ets-2 binding site. A: The core 6 bp Ets-2 binding sequence (À77 to À72 bp) in the oIFNt-o10's promoter region and the equivalent 6 bp sequence of oIFNt-o8 are shown. B: Transcriptional activities of wild-type oIFNt-o10 and -o8, and those of o10-M6 and o8-M6. Results are expressed as relative CAT activity to that of the oIFNt-o10-reporter plasmid and values represent means AE SEM. Results with different letters differ at P < 0.01 (n ¼ 4 each). Figure 4A is indicated in boxes and a 10 bp Ets-2 sequence is underlined.
B:
Transcriptional activities of wild-type oIFNt-o10 and -o8, and those of o10-M6 and o8-M22 in which the 23 bp was exchanged with the 22 bp of oIFNt-o10. Results are expressed as relative CAT activity to that of the oIFNt-o10-reporter plasmid and values represent means AE SEM. Results with different letters differ at P < 0.01 (n ¼ 4 each). Fig. 6 . Electrophoretic mobility shift assay (EMSA) analyses on 22 and 23 bp of oIFNt-o10 and -o8 promoter regions. The sequences of oIFNt-o10 and -o8 probes are shown in Figure 5A . Bindings of nuclear protein extracts from JEG3 cells to g-32 P labeled oIFNt-o10 or -o8 were examined. Specificities of the shifted bands were examined following addition of non-labeled oligonucleotide of the same sequences, Ets-2 consensus sequences (Ets C) and unrelated Sp-1 consensus sequence. A representative EMSA gel from three independent analyses is shown. Fig. 7 . EMSA analyses on o8-M6 probe. The oIFNt-o8's 23 bp region inserted with the core 6 bp Ets-2 binding site from oIFNt-o10 (5 0 -GAAAACGCAACAGGAAGTGAGAG-3 0 , Ets-2 site inserted is underlined) was examined using nuclear extracts from JEG3 cells. Ovine IFNt-o10 (22 bp) and -o8 (23 bp) probes were used as controls. Specificity of protein binding to IFNt-o10 and -o8 probes was examined using non-labeled oligonucleotide of the same sequences (oIFNt-o10, -o8, or o8-M6). A representative EMSA gel from three independent analyses is shown. used to study regulatory mechanisms for IFNt gene transcription. In fact, human trophoblast derived JEG3 and JAR cells have been shown to support the transcriptional activity of IFNt-reporter constructs (Leaman et al., 1994; Yamaguchi et al., 1999) . In this study, the CAT activity resulted from the upstream region of wildtype oIFNt-o10, -o8 and -o2 genes transfected to JEG3 cells reflected the expression levels of these genes in utero (Nephew et al., 1993) . These results indicate that the expressions of oIFNt genes are regulated at transcriptional level and transient transfection analyses using JEG3 cells is one system for examining the regulatory mechanisms of oIFNt gene expressions.
The upstream regions at À452 bp of oIFNt-o10, -o8, and -o2 genes were digested with Hind III, resulting in the separation of distal enhancer (À654 to À452 bp) and proximal promoter (À451 to þ51 bp) regions. When the enhancer and promoter regions were interchanged heterologously and examined for their transactivation, the promoter of oIFNt-o10 gene's proximal region was shown to possess strong activation (Fig. 1) . As shown in Figure 4A , only the oIFNt-o10 gene contains the Ets-2 binding sequence at À77 to À72 bp of the promoter region and this difference between oIFNt-o10 and oIFNt-o8/o2 genes was thought to determine the transcriptional expression levels of these genes. This hypothesis was confirmed by point mutation analyses of Ets-2 binding site, and by the 6 bp insertion of the oIFNt-o8 sequence into the core 6 bp Ets-2 binding sequence of oIFNt-o10 (Figs. 2-4 ). Similar to our previous observation (Yamaguchi et al., 2000) , the binding of Ets-2 to the oIFNt-o10's short promoter region was demonstrated by the EMSA analyses (Fig. 6 ). This result, the requirement of Ets-2 for oIFNt-reporter transactivation, agrees with previous observation made by Ezashi et al. (1998) .
It appeared that a protein binding to the Ets-2 site dictated the oIFNt gene transcription, however, insertion of the core 6 bp sequence of Ets-2 binding site (CAGGAA) failed to increase the transactivation of oIFNt-o8-reporter construct (Fig. 4) . As shown in Figure 5A , it should be noted that because nucleotide sequences at both sides of this 6 bp were the same between oIFNt-o10 and -o8, the Ets-2 site examined was the same as the 10 bp consensus Ets-2 site (Wasylyk et al., 1993) . Thus, a lack of transactivation with the 6-bp insertion was not due to insufficient Ets-2 binding site. When the 22 bp sequence from the oIFNt-o10 gene promoter, including the Ets-2 binding site (GAAAAC-AAACAGGAAGTGAGGG; 10 bp Ets-2 site underlined), was inserted into the equivalent region of oIFNt-o8-reporter plasmid, this mutation construct, o8-M22, increased the CAT activity to the level exhibited by the oIFNt-o10 construct (Fig. 5B) . From these results, it was suspected that Ets-2 protein did not bind to the core 6 bp Ets-2 binding sequence that had been inserted into the oIFNt-o8's promoter region, o8-M6. Therefore, a different binding pattern was expected in EMSA with the o8-M6 probe, but the binding pattern was the same as the oIFNt-o10 probe except that the binding signal of o8-M6 appeared to be weaker (Fig. 7) . It is possible that the flanking sequence around Ets-2 site may position the Ets-2 site such that it can act with other proteins, and that the sequence per se may not be relevant but the position of the Ets binding site is critical. It is likely that in addition to the 10 bp Ets-2 binding site, the 22 bp sequence may possess another transcription binding site(s), which increases oIFNt-o10 gene transcription.
By searching for a possible transcription factor that binds to this oIFNt-o10 short promoter region, but does not bind to the equivalent region of oIFNt-o8/o2 gene, a candidate protein, hepatocyte nuclear factor-3 beta (HNF-3b), was found. Co-transfection analyses with expression vector of HNF-3b (Dr. R.H. Costa, University of Illinois) and point mutation analyses to the HNF-3b binding site of the oIFNt-o10 short promoter region were performed, however, our hypothesis was not verified with these experiments (unpublished observations). Within the 23 bp region of the oIFNt-o8/o2 gene, a nuclear factor Oct-4 binding site resides at the same location as the Ets-2 site exists in the oIFNt-o10 gene. In the porcine and bovine species, however, the expression of Oct-4 is not restricted to ICM (Kirchhof et al., 2000) , and has been demonstrated to inhibit bIFNt gene transcription by binding to Ets-2 protein (Ezashi et al., 2001) . For these reasons, co-transfection of the oIFNto10-reporter plasmid with Oct-4 expression plasmid (Dr. C. Meno, Osaka University, Japan) was also performed, resulting in the reduction of oIFNt-o10-reporter transactivation (data not shown). Furthermore, identity of a higher molecular weight protein, which was found in the EMSA experiment with the oIFNt-o8/o2 probe, was not determined in this study. It is possible, however, that instead of Ets-2 site, the binding of Oct-4 itself or together with other transcription factor(s) to this 23 bp region may repress the expression of oIFNt-o8/o2 gene in vivo.
In summary, using the 5 0 -upstream region of oIFNto10, -o8, and -o2, the 22 bp with Ets-2 binding sequence of oIFNt-o10 was found to be the short promoter region required for the full activation. From this and the previous observations on IFNt genes' transcriptional regulation, Ets-2 should be considered an essential factor for the expression of oIFNt-o10 gene (Yamaguchi et al., 2000; Ezashi et al., 2001 ). While Ets-2 was the factor critical for the oIFNt-reporter transactivation, point mutation to the AP-1 binding site decreased the degree of oIFNt-reporter transactivation ( Fig. 2 and 3) . Considering this observation with the results from Yamaguchi et al. (1999 Yamaguchi et al. ( , 2000 , AP-1 might also be the transactivation molecule of oIFNt genes acting in concert with Ets-2 for higher degree of transcription (Gutman and Wasylyk, 1990; McCarthy et al., 1997) . Since AP-1 and Ets-2 are relatively common transcription factors detected in many cell types, another factor, which by itself determines spatial and/or temporal expression of oIFNt genes, is required. A factor that dictates AP-1 and Ets-2 to be spatial and/or temporal expression may also exist in the regulation of IFNt gene expression.
